ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement
ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with AlgenScribe SAS (‘AlgenScribe’). This is a non-exclusive…
Where health news comes full circle!